MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,138,720 | -62.8% | 268,000 | -41.2% | 0.60% | -60.7% |
| Q2 2023 | $105,336,000 | +8.4% | 456,000 | +13.7% | 1.52% | +9.0% |
| Q1 2023 | $97,146,260 | +60.9% | 401,000 | +92.8% | 1.40% | +32.9% |
| Q4 2022 | $60,372,000 | -24.8% | 208,000 | -83.2% | 1.05% | -24.4% |
| Q3 2022 | $80,328,000 | +2.0% | 1,236,000 | +12.4% | 1.39% | +1.4% |
| Q2 2022 | $78,738,000 | -17.9% | 1,100,000 | +12.5% | 1.37% | -26.0% |
| Q1 2022 | $95,961,000 | +0.7% | 978,000 | -13.0% | 1.86% | +19.1% |
| Q4 2021 | $95,248,000 | +15.2% | 1,124,000 | +8.5% | 1.56% | +11.4% |
| Q3 2021 | $82,662,000 | +43.3% | 1,036,000 | +75.0% | 1.40% | +35.7% |
| Q2 2021 | $57,667,000 | +40.9% | 592,000 | +69.1% | 1.03% | +9.8% |
| Q1 2021 | $40,940,000 | +16.5% | 350,000 | +10.8% | 0.94% | -21.3% |
| Q4 2020 | $35,130,000 | +6.4% | 316,000 | +13.7% | 1.20% | -0.2% |
| Q3 2020 | $33,007,000 | +17.5% | 278,000 | +12.1% | 1.20% | -2.8% |
| Q2 2020 | $28,086,000 | +94.8% | 248,000 | +14.8% | 1.23% | +38.1% |
| Q1 2020 | $14,420,000 | -1.1% | 216,000 | +35.0% | 0.89% | +6.1% |
| Q4 2019 | $14,578,000 | +56.6% | 160,000 | +48.1% | 0.84% | +36.3% |
| Q3 2019 | $9,312,000 | -78.2% | 108,000 | -73.5% | 0.62% | -77.1% |
| Q2 2019 | $42,762,000 | -19.7% | 408,000 | -4.0% | 2.70% | -7.5% |
| Q1 2019 | $53,236,000 | +210.8% | 425,000 | +431.2% | 2.91% | +183.5% |
| Q3 2018 | $17,130,000 | +43.8% | 80,000 | -21.6% | 1.03% | +12.8% |
| Q1 2018 | $11,913,000 | +116.3% | 102,000 | +70.0% | 0.91% | +65.9% |
| Q4 2017 | $5,507,000 | -42.3% | 60,000 | -71.7% | 0.55% | -51.1% |
| Q3 2017 | $9,536,000 | +108.0% | 212,000 | -24.8% | 1.12% | +92.3% |
| Q2 2017 | $4,585,000 | +132.6% | 282,000 | +120.3% | 0.58% | +43.5% |
| Q1 2017 | $1,971,000 | +6.7% | 128,000 | +3.2% | 0.41% | -6.9% |
| Q4 2016 | $1,848,000 | +10.4% | 124,000 | -6.1% | 0.44% | -18.6% |
| Q3 2016 | $1,674,000 | – | 132,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |